Reshape Lifesciences Inc (RSLS)

$5.30 0.00 (0.00%)

9:36 EDT RSLS Stock Quote Delayed 30 Minutes

OBLN Stock: 12 Things to Know About the ReShape-Obalon Merger as Shares Balloon Higher

By William White, InvestorPlace Writer Jan 20, 2021

Obalon Therapeutics (OBLN) stock is skyrocketing on Wednesday after announcing merger plans with ReShape Lifesciences (RSLS).

ReShape Lifesciences: Burning Fat Wads of Shareholders’ Cash

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 5

Day's Range 5.30 - 5.30

52-Week Range 1.14 - 14.00

Dividend & Yield N/A (N/A)

RSLS Stock Predictions, Articles, and Reshape Lifesciences Inc News

From the Web

ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results

From ReShape Lifesciences Inc. Mar 10, 2021

SAN CLEMENTE, CA / ACCESSWIRE / March 10, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, today reported financial and operational results for the fourth quarter and full year ended December 31, 2020. Recent Highlights and Accomplishments - Entered into a definitive merger agreement with Obalon Therapeutics, Inc., a company focused on developing and commercializing novel technologies for weight

Reshape Lifesciences to Report Fourth Quarter and Full Year 2020 Financial and Operational Results on Wednesday, March 10, 2021

From ReShape Lifesciences Inc. Mar 8, 2021

Webinar to discuss results on March 10, 2021 at 4:30 p.m. E.T SAN CLEMENTE, CA / ACCESSWIRE / March 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that it will report its fourth quarter and full year 2020 financial and operational results on Wednesday, March 10, 2021 after the close of the U.S. financial

ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering

From ReShape Lifesciences Inc. Jan 20, 2021

SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 /ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger agreement with Obalon Therapeutics, Inc., which is listed on the NASDAQ Capital Market, a company focused on developing and commercializing novel technologies for weight loss, under which ReShape and Obalon will combine in an all-stock transaction. Under

ReShape Lifesciences Announces Third Quarter 2020 Financial and Operational Results

From ReShape Lifesciences Inc. Nov 12, 2020

SAN CLEMENTE, CA / ACCESSWIRE / November 12, 2020 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, today reported financial and operational results for the three months ended September 30, 2020. Recent Highlights and Accomplishments - Increased third-quarter revenues by 3% to $3.6 million for the three months ended September 30, 2020, as compared to $3.5 million for the same period in 2019, despite

ReShape Lifesciences to Report Third Quarter 2020 Financial and Operational Results on Thursday, November 12, 2020

From ReShape Lifesciences Inc. Nov 10, 2020

SAN CLEMENTE, CA / ACCESSWIRE / November 10, 2020 /ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that it will report its third quarter 2020 financial and operational results on Thursday, November 12, 2020 after the close of the U.S. financial markets. Management will post a webinar to discuss ReShape's financial

ReShape Lifesciences's diabetes neuromodulation device shows encouraging effect in preclinical studies (OTCMKTS:RSLS)

From Seeking Alpha Sep 10, 2020

ReShape Lifesciences (OTCQB:RSLS +11.0%) has announced preclinical research demonstrating its investigational Diabetes Bloc-Stim Neuromodulation (DBSN) device, for the treatment of type 2 diabetes mellitus, was well-tolerated and met the study endpoints.Histopathology of organ systems effected by the neuromodulation demonstrated healthy tissue.

Reshape Lifesciences Inc (RSLS)

OBLN Stock: 12 Things to Know About the ReShape-Obalon Merger as Shares Balloon Higher

ReShape Lifesciences: Burning Fat Wads of Shareholders’ Cash

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Reshape Lifesciences Inc (RSLS)

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

RSLS Stock Predictions, Articles, and Reshape Lifesciences Inc News

Subscriber Sign in